中新网北京6月20日电(记者吕少威陈杭)2025年"活力中国调研行"北京市主题采访活动20日走进中关村 国家自主创新示范区展示中心(下称"中关村展示中心")常设展，探寻北京科技创新"密码"，感受北京乃 至中国创新脉动的勃勃生机。 2010年，中关村展示中心投入建设，2011年7月1日正式挂牌，成为集中展示中关村及北京自主创新成就 的平台和窗口。 据了解，自对外展出以来，中关村展示中心常设展经过多次升级改造。当前的常设展于今年3月改造完 成，面积1万平方米，以"新质生产力看北京"为主题，设置序厅、改革赋能新质生产力、加大高质量科 技供给、布局建设未来产业、培育壮大新兴产业、打造开放创新生态等展区。 常设展集中展示350多家在京科研机构、企业在人工智能+、商业航天、高端医疗器械等前沿科技领域 的490多项技术、产品，展现北京市以科技创新引领新质生产力发展、建设现代化产业体系的最新成 果。2024年，常设展接待人员同比增长328%；2025年1月至5月，接待人员同比增长203.77%。 在北京戴纳实验科技股份有限公司展台，该公司研发的自动称量机器人正在对量杯中的黏稠液体进行称 重，一旁的显示屏上立刻显示出了液体重量 ...

普京：担心世界可能会滑向第三次世界大战 跟踪中东局势动态 +订阅 金十数据6月21日讯，俄罗斯总统普京周五在圣彼得堡国际经济论坛（SPIEF）的全体会议回答记者提 问时表示，他担心世界可能滑向第三次世界大战。"这确实让我担心。我说这话没有任何讽刺或玩笑。 当然，发生冲突的可能性太大了，而且还在增加。" ...

订阅美联储动态 +订阅 美联储巴尔金：不急于降息，不能忽视关税带来的通胀风险 金十数据6月21日讯，美联储巴尔金周五表示，鉴于新进口税可能推高通胀的风险仍未解决，且美国就 业市场和消费者支出坚挺，不急于降息。在接受路透采访时指出，巴尔金指出，"我不认为这些数据会 让我们急于降息……我非常清楚，我们已经四年没有达到通胀目标了。"巴尔金所在地区（里士满）的 企业仍预计，随着新关税生效，价格将在今年晚些时候上涨，而且未来几个月进口关税可能会进一步上 涨。此外，他说，失业率仍保持在4.2%的低位，企业似乎没有出现大规模裁员的迹象，这将削弱美联 储维持最大就业的另一个目标。鉴于关税最终结果仍悬而未决，巴尔金表示，"我得说，我们必须作出 的反应仍然是观望。 观望不是踩刹车。只是不要踩油门而已。" ...

It has been about a month since the last earnings report for Medtronic (MDT) . Shares have added about 6% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Medtronic due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns ou ...

It has been about a month since the last earnings report for Target (TGT) . Shares have added about 0.1% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Target due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out, ...

It has been about a month since the last earnings report for EnerSys (ENS) . Shares have added about 2.8% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is EnerSys due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out, ...

A month has gone by since the last earnings report for Wix.com (WIX) . Shares have added about 2.3% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Wix.com due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out, fresh ...

A month has gone by since the last earnings report for Zoom Communications (ZM) . Shares have lost about 5.6% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Zoom due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out ...

Key Takeaways SSUMY, IHICY, NOMD, GLDD and NGS show rising cash flow above their five-year average per share levels. Each stock has seen upward EPS estimate revisions in the past two months, reflecting improving outlooks. All five have strong VGM Scores and meet the criteria, suggesting solid financial and operational health.Picking profit-making stocks for investments might be popular but not flawless. This is because even a profit-making company can have a deficiency of cash flow and become bankrupt whi ...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased Iovance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...